Intravital imaging of tumor apoptosis with FRET probes during tumor therapy

Mol Imaging Biol. 2010 Jan-Feb;12(1):63-70. doi: 10.1007/s11307-009-0235-y. Epub 2009 Jun 19.

Abstract

Purpose: The aim of the study is to dynamically and non-invasively monitor the apoptosis events in vivo during photodynamic therapy (PDT) and chemotherapy.

Procedures: A FRET probe, SCAT3, was utilized to determine activation of caspase-3 during tumor cell apoptosis in mice, induced by PDT, and cisplatin treatments. Using this method, dynamics of caspase-3 activation was observed both in vitro and in vivo.

Results: Analysis of the fluorescent missions from tumor cells indicated that the caspase-3 activation started immediately after PDT treatment. In contrast, the caspase-3 activation started about 13 and 36 h after cisplatin treatment in vitro and in vivo, respectively.

Conclusions: FRET could be used effectively to monitor activation of caspase-3 in living organism. This method could be used to provide rapid assessment of apoptosis induced by anti-tumor therapies for improvement of treatment efficacy.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis* / drug effects
  • Caspase 3 / metabolism
  • Cell Line, Tumor
  • Cisplatin / pharmacology
  • Enzyme Activation / drug effects
  • Fluorescence Resonance Energy Transfer*
  • Humans
  • Mice
  • Mice, Nude
  • Microscopy, Fluorescence
  • Molecular Imaging / methods*
  • Neoplasms / enzymology
  • Neoplasms / pathology*
  • Neoplasms / therapy*
  • Photochemotherapy
  • Tissue Culture Techniques

Substances

  • Caspase 3
  • Cisplatin